R Hare Selected Research

evernimicin

3/2001	In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophages.
1/2001	Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Hare Research Topics

Disease

3	Heart Failure 08/2004 - 06/2002
3	Infections 08/2001 - 12/2000
2	Body Weight (Weight, Body) 01/2001 - 03/2000
1	Invasive Fungal Infections 01/2006
1	Exanthema (Rash) 01/2006
1	Zygomycosis (Phycomycosis) 01/2006
1	Left Ventricular Dysfunction 08/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2003
1	Systemic candidiasis 08/2001
1	Pulmonary Aspergillosis 03/2001
1	Legionnaires' Disease (Legionnaire's Disease) 12/2000
1	Mycoses (Diseases, Fungus) 03/2000

Drug/Important Bio-Agent (IBA)

2	posaconazole FDA Link 01/2006 - 03/2000
2	pro-brain natriuretic peptide (1-76)IBA 08/2004 - 06/2002
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2004 - 06/2002
2	DiureticsIBA 08/2004 - 06/2002
2	CytokinesIBA 08/2001 - 03/2001
2	evernimicinIBA 03/2001 - 01/2001
1	SolutionsIBA 01/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2002
1	EnzymesIBA 08/2001
1	ImmunosorbentsIBA 08/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2001
1	Interleukin-12 (IL 12)IBA 08/2001
1	Proteins (Proteins, Gene)FDA Link 08/2001
1	Interferon-gamma (Interferon, gamma)IBA 12/2000
1	Interleukin-18 (Interleukin 18)IBA 12/2000
1	AzolesIBA 03/2000
1	Antifungal AgentsIBA 03/2000

Therapy/Procedure

1	Salvage Therapy 01/2006
1	Therapeutics 01/2006
1	Secondary Prevention 07/2003